Background: The expression of mesoderm-specific transcript (Mest) is regulated by genomic imprinting where only the paternal allele is active for transcription. Mest is a candidate gene for Silver-Russell Syndrome, and hypermethylation of Mest promoter is associated with oligozoospermia. In addition, Loss of imprinting (LOI) is often associated with various neurodegenerative diseases and cancers. Since aberrant Mest hypermethylation and LOI are implicated in various diseases, it is vital to study Mest promoter hypermethylation and its functional role in AD patients.
Methods: To assess the Mest promoter methylation, bisulfite sequencing technique was used. CRIPSR/Cas9 system was used to generate the Mest knockout (KO) in both embryonic carcinoma and mouse embryonic stem cells. Lentiviral Split-Cas9 system (LSC-5) was employed to generate inducible Mest KO in neurons.
Results: We found that Mest promoter is hypermethylated, which led to the reduction of Mest mRNA levels and activation of Wnt signaling in the brain tissues of AD patients. Mest KO in both embryonic carcinoma and mouse embryonic stem cells leads to neuronal differentiation arrest. Depletion of Mest in primary hippocampal neurons via lentivirus expressing sh-Mest or inducible KO system caused neurodegeneration. Notably, depletion of Mest in rat primary cortical neurons leads to tau phosphorylation at S199 and T231 sites.
Conclusion: Our study has unfolded the epigenetic modification; Mest promoter hypermethylation in AD. Biochemically, we have linked this with Wnt signaling activation and Tau phosphorylation in neurons.